Sign inJoin waitlistJoin the waitlist

Michael Para

Infectious Disease

Credentials: · ·

History

University of Chicago
1977–1979
Internal Medicine
1974–1977
Ohio State Univ Coll of Med
1970–1974

Research

Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection
The Journal of Infectious Diseases · 2005 · 752 citations
The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind,…
Annals of Internal Medicine · 1990 · 643 citations
Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease
Annals of Internal Medicine · 2001 · 480 citations

Henry Nasrallah
10 papers
Margaret Fischl
8 papers
RR
Richard Reichman
8 papers
JM
John Mellors
7 papers
Ann Collier
6 papers
LD
Lisa Demeter
6 papers
DK
David Katzenstein
5 papers
GB
Gary Bollin
5 papers · 5 as a fellow
MA
Mary Albrecht
5 papers
Rajesh Gandhi
5 papers
SH
Scott Hammer
5 papers
Daniel Kuritzkes
4 papers

Grants

General Clinical Research Center
National Center for Research Resources · M01
Project lead · $733.8K · Ohio State University
1997–2008
Clinical Center
National Heart, Lung, and Blood Institute · N01
Contact PI · $497.5K · Ohio State University
1994–2000
Adult Aids Clinical Trials Unit
National Institute of Allergy and Infectious Diseases · U01
Project lead · Ohio State University

Clinical trials

Anti-HIV Activity and Safety of 3 Different Doses of Mifepristone in HIV Infected People
Study chair · Completed · Phase 1, Phase 2
National Institute of Allergy and Infectious Diseases (NIAID)
2005